Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry.

This publication has 15 references indexed in Scilit:

• What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester?
  Prenatal Diagnosis, 2001
• One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester
  BJOG: An International Journal of Obstetrics and Gynaecology, 2000
• Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free beta hCG: a seven year review
  BJOG: An International Journal of Obstetrics and Gynaecology, 1999
• A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A
  Ultrasound in Obstetrics & Gynecology, 1999
• Maternal age‐ and gestation‐specific risk for trisomy 21
  Ultrasound in Obstetrics & Gynecology, 1999
• Accuracy of Down's Syndrome Risks Produced in a Prenatal Screening Program
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1999
• UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation
  The Lancet, 1998
• Free β-hCG as first-trimester marker for fetal trisomy
  The Lancet, 1992
• Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
  BMJ, 1992
• Ultrasound and Biochemical Assessment of First Trimester Pregnancy
  Published by Springer Nature ,1991